The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Assessment of time from cytoreductive nephrectomy (CN) to initiation of targeted therapy (TT) in patients with metastatic renal cell carcinoma (mRCC).
Winston Vuong
No relevant relationships to disclose
Mark Chang
No relevant relationships to disclose
Nora Ruel
No relevant relationships to disclose
Joann Hsu
No relevant relationships to disclose
Courtney Carmichael
No relevant relationships to disclose
Robert A. Figlin
No relevant relationships to disclose
Sumanta Kumar Pal
No relevant relationships to disclose